Knee osteoarthritis: key treatments and implications for physical therapy

LO Dantas, T de Fátima Salvini… - Brazilian journal of physical …, 2021 - Elsevier
Background Knee osteoarthritis (OA) is a chronic progressive disease that imparts a
substantial socioeconomic burden to society and healthcare systems. The prevalence of …

Arthroscopic versus open treatment of femoroacetabular impingement: a systematic review of medium-to long-term outcomes

BU Nwachukwu, BJ Rebolledo… - … American journal of …, 2016 - journals.sagepub.com
Background: Surgical treatment of symptomatic femoroacetabular impingement (FAI) aims to
improve symptoms and potentially delay initiation of hip osteoarthritis and prevent …

Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria

M Balwani, E Sardh, P Ventura, PA Peiró… - New England journal …, 2020 - Mass Medical Soc
Background Up-regulation of hepatic delta-aminolevulinic acid synthase 1 (ALAS1), with
resultant accumulation of delta-aminolevulinic acid (ALA) and porphobilinogen, is central to …

Quantifying success after total shoulder arthroplasty: the minimal clinically important difference

R Simovitch, PH Flurin, T Wright, JD Zuckerman… - Journal of shoulder and …, 2018 - Elsevier
Background Knowledge of the minimal clinically important difference (MCID) for different
shoulder outcome metrics and range of motion after total shoulder arthroplasty (TSA) can be …

The minimal clinically important difference for Knee Society Clinical Rating System after total knee arthroplasty for primary osteoarthritis

WC Lee, YH Kwan, HC Chong, SJ Yeo - Knee Surgery, Sports …, 2017 - Springer
Abstract Purpose The Knee Society Clinical Rating System (KS) is one of the most popular
tools used to assess patient outcome after total knee arthroplasty (TKA), but its minimal …

Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study

P Ventura, HL Bonkovsky, L Gouya… - Liver …, 2022 - Wiley Online Library
Abstract Background & Aims Upregulation of hepatic delta‐aminolevulinic acid synthase 1
with accumulation of potentially toxic heme precursors delta‐aminolevulinic acid and …

Reducing opioid use for chronic pain with a group-based intervention: a randomized clinical trial

HK Sandhu, K Booth, AD Furlan, J Shaw, D Carnes… - JAMA, 2023 - jamanetwork.com
Importance Opioid use for chronic nonmalignant pain can be harmful. Objective To test
whether a multicomponent, group-based, self-management intervention reduced opioid use …

Cemented versus cementless total knee arthroplasty of the same modern design: a prospective, randomized trial

D Nam, CM Lawrie, R Salih, CR Nahhas, RL Barrack… - JBJS, 2019 - journals.lww.com
Background: Highly porous surfaces promoting biologic fixation have renewed interest in
cementless total knee arthroplasty (TKA), but the potential for failed biologic fixation remains …

Minimum clinically important difference: current trends in the orthopaedic literature, part II: lower extremity: a systematic review

AG Copay, B Eyberg, AS Chung, KS Zurcher… - JBJS …, 2018 - journals.lww.com
Background: The minimum clinically important difference (MCID) attempts to define the
patient's experience of treatment outcomes. Efforts at calculating the MCID have yielded …

[HTML][HTML] Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial

DJ Kuter, HL Bonkovsky, S Monroy, G Ross… - Journal of …, 2023 - Elsevier
Background & Aims Acute hepatic porphyria (AHP) is caused by defects in hepatic heme
biosynthesis, leading to disabling acute neurovisceral attacks and chronic symptoms. In …